Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Orthofix Medical
OFIX
$477M
| $7.18M | ﹤0.01% |
179,025
+10,527
| +6% | +$445K |
|
2177
StepStone Group
STEP
$3.61B
| $7.17M | ﹤0.01% |
208,275
+46,775
| +29% | +$1.56M |
|
|
LDL
2178
DELISTED
Lydall, Inc.
LDL
| $7.14M | ﹤0.01% |
118,006
+1,716
| +1% | +$66K |
|
|
AGEN
2179
Agenus
AGEN
$312M
| $7.14M | ﹤0.01% |
66,232
+12,381
| +23% | +$928K |
|
2180
Universal Electronics
UEIC
$57.8M
| $7.11M | ﹤0.01% |
146,629
+7,391
| +5% | +$384K |
|
2181
Nomad Foods
NOMD
$1.66B
| $7.11M | ﹤0.01% |
251,441
-3,942
| -2% | -$116K |
|
|
HSII
2182
DELISTED
Heidrick & Struggles
HSII
| $7.1M | ﹤0.01% |
159,403
+16,538
| +12% | +$691K |
|
2183
Clover Health Investments
CLOV
$2.2B
| $7.09M | ﹤0.01% |
532,100
+23,805
| +5% | +$234K |
|
2184
AngioDynamics
ANGO
$611M
| $7.07M | ﹤0.01% |
260,650
+5,751
| +2% | +$140K |
|
2185
Tactile Systems Technology
TCMD
$635M
| $7.06M | ﹤0.01% |
135,726
+5,300
| +4% | +$287K |
|
2186
Madrigal Pharmaceuticals
MDGL
$10.8B
| $7.04M | ﹤0.01% |
72,282
+7,923
| +12% | +$938K |
|
2187
ImmunityBio
IBRX
$7.51B
| $7.02M | ﹤0.01% |
491,859
+234,631
| +91% | +$3.88M |
|
2188
StoneX
SNEX
$9.26B
| $7.01M | ﹤0.01% |
585,093
+8,621
| +1% | +$111K |
|
2189
Collegium Pharmaceutical
COLL
$1.15B
| $6.99M | ﹤0.01% |
295,455
+60,294
| +26% | +$1.39M |
|
2190
America's Car Mart
CRMT
$26.6M
| $6.98M | ﹤0.01% |
49,250
+4,193
| +9% | +$628K |
|
2191
Replimune Group
REPL
$941M
| $6.97M | ﹤0.01% |
181,294
+7,575
| +4% | +$259K |
|
|
AVTA
2192
DELISTED
Avantax, Inc. Common Stock
AVTA
| $6.95M | ﹤0.01% |
401,490
+45,485
| +13% | +$747K |
|
2193
Atlanta Braves Holdings Series B
BATRK
$3.26B
| $6.94M | ﹤0.01% |
249,827
+5,962
| +2% | +$163K |
|
2194
Driven Brands
DRVN
$2.35B
| $6.93M | ﹤0.01% |
224,265
+4,865
| +2% | +$137K |
|
2195
Seaboard Corp
SEB
$4.23B
| $6.92M | ﹤0.01% |
1,789
+32
| +2% | +$120K |
|
|
TRTX
2196
TPG RE Finance Trust
TRTX
$612M
| $6.84M | ﹤0.01% |
508,665
+61,365
| +14% | +$786K |
|
2197
United Fire Group
UFCS
$1.32B
| $6.83M | ﹤0.01% |
246,366
+15,679
| +7% | +$488K |
|
|
YMAB
2198
DELISTED
Y-mAbs Therapeutics
YMAB
| $6.83M | ﹤0.01% |
202,119
+11,601
| +6% | +$372K |
|
|
RDUS
2199
DELISTED
Radius Health, Inc.
RDUS
| $6.8M | ﹤0.01% |
372,920
+9,018
| +2% | +$179K |
|
2200
Corsair Gaming
CRSR
$1.13B
| $6.78M | ﹤0.01% |
203,689
+10,844
| +6% | +$357K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.